纳米粒子的最新进展与PD-L1基础的疗法结合化学疗法治疗肺癌
Abdulkareem Shareef1, Hayder Naji Sameer2, Ahmed Yaseen3
1Ahl Al Bayt University, Kerbala, Iraq.
Critical reviews in oncology/hematology
|August 4, 2025
概括
纳米粒子可以通过有效地提供药物并减少副作用来改善肺癌 (LC) 免疫化疗. 本综述探讨了纳米颗粒用于LC治疗的应用,重点关注克服临床挑战.
科学领域:
- 在瘤学瘤学.
- 纳米技术纳米技术
- 免疫疗法是一种免疫疗法.
背景情况:
- 肺癌 (LC) 仍然是全球癌症死亡的主要原因.
- 免疫检查点抑制剂 (ICI) 在非小细胞肺癌 (NSCLC) 中表现有前途,现在已被批准用于广泛阶段的小细胞肺癌 (SCLC).
- 将ICI与化疗 (CHT) 结合起来可以改善生存率,但会增加毒性风险,包括免疫相关的不良事件.
研究的目的:
- 审查目前针对LC的免疫化学疗法 (ICHT) 策略.
- 探索纳米颗粒 (NP) 在减轻ICHT对LC的毒性方面的作用.
- 讨论基于NP的LC治疗的临床局限性和潜在解决方案.
主要方法:
- 对最近的研究进行了全面的文献综述.
- 对LC治疗中NP的临床前和临床数据的分析.
- 检查NP传递系统和免疫调节能力.
主要成果:
- 在ICHT中,NP可以保护和控制药物释放.
- 临床前研究表明NP在LC的运输和免疫调节方面的有效性.
- 不同的NP类型显示了减轻ICHT相关毒性的潜力.
结论:
- 基于纳米粒子的药物输送对于提高肺癌免疫化疗的安全性和有效性至关重要.
- 需要进一步的研究和临床策略来克服NP在LC治疗中整合NP的现有局限性.
关键词:
化疗 化疗是一种化学疗法.药物输送方法 药物输送方法免疫化疗是一种免疫化学疗法.免疫疗法是一种免疫疗法.肺癌是一种肺癌.在NSCLCLC中,我们可以看到.纳米颗粒是指一个纳米粒子.在PD-L1中.在SCLC中,SCLC是最重要的.更多相关视频
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.7K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K